Receptors for prolactin, somatostatin, and luteinizing hormone-releasing hormone in experimental prostate cancer after treatment with analogs of luteinizing hormone-releasing hormone and somatostatin.

Documenti analoghi

• Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
  di: Schally, A V, et al.
  Pubblicazione: (1987)
• Inhibition of growth of a prolactin-secreting pituitary tumor in rats by analogs of luteinizing hormone-releasing hormone and somatostatin.
  di: de Quijada, M G, et al.
  Pubblicazione: (1983)
• Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone.
  di: Paz-Bouza, J I, et al.
  Pubblicazione: (1987)
• Inhibition of growth of a prolactin and growth hormone-secreting pituitary tumor in rats by D-tryptophan-6 analog of luteinizing hormone-releasing hormone.
  di: Torres-Aleman, I, et al.
  Pubblicazione: (1985)
• Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin.
  di: Szende, B, et al.
  Pubblicazione: (1989)